Kryštof Vladimír

Journals

VARVUOLYTE, G., E. ŘEZNÍČKOVÁ, S. KRIKSTOLE, R. TAMULINE, A. BIELIAUSKAS, L. MALINA, V. VOJÁČKOVÁ, Z. DUBEN, H. KOLÁŘOVÁ, N. KLEIZIENE, E. ARBACIAUSKIENE, A. ŽUKAUSKAITE, V. KRYŠTOF, A. SACKUS
Synthesis and photo-induced anticancer activity of new 2-phenylethenyl-1H-benzo[e]indole dyes. European Journal of Medicinal Chemistry. 2024, 277, 116777, ISSN: 0223-5234 , PMID: 39173284,  PDF.
VARVUOLYTE, G., E. ŘEZNÍČKOVÁ, A. BIELIAUSKAS, N. KLEIZIENE, V. VOJÁČKOVÁ, A. OPICHALOVA, A. ŽUKAUSKAITE, V. KRYŠTOF, A. SACKUS
Synthesis and photodynamic activity of new 5-[(E)-2-(3-alkoxy-1-phenyl-1H-pyrazol-4-yl)ethenyl]-2-phenyl-3H-indoles. Archiv der Pharmazie. 2024, ISSN: 0365-6233, PMID: 38969965,  PDF.
DELGADO, T., V. D., H. DOSTÁLOVÁ, V. KRYŠTOF, V. VOJÁČKOVÁ, R. JORDA, A. CASTRO, J. BERTRAND, G. RIVERA, M. FAUNDEZ, M. STRNAD, C. ESPINOSA-BUSTOS, O. SALAS C.
New Inhibitors of Bcr-Abl Based on 2,6,9-Trisubstituted Purine Scaffold Elicit Cytotoxicity in Chronic Myeloid Leukemia-Derived Cell Lines Sensitive and Resistant to TKIs. Pharmaceutics. 2024, 16(5), 649, ISSN: 1999-4923, PMID: 38794311,  PDF.

Doctoral mentorship

Trofimenková Dominika

Cytoprotective effects of novel selenium-based compounds

Status: Ongoing from 2023.